| News Article | Prefilled Syringes to Exceed 3 Billion Units in 2012 | mksmith | 0 | 3 weeks 8 hours ago |
| News Article | MS Patients May Soon Benefit from a New Generation of Oral Drugs | mksmith | 0 | 12 weeks 9 hours ago |
| News Article | Pain Drug Patches and Gels on Track to Exceed $8 Billion in 2012 | mksmith | 0 | 16 weeks 8 hours ago |
| News Article | Injectable Drugs Benefiting from Advances in Evolving Device Designs | mksmith | 0 | 19 weeks 10 hours ago |
| News Article | Market Dynamics Driving Packaging Strategies for Injectables | mksmith | 0 | 23 weeks 2 days ago |
| News Article | Commercialization of Protein Drugs Will Create an $80 B. Market By 2012 | mksmith | 0 | 26 weeks 2 days ago |
| News Article | Targeting the Immune System a Profitable Strategy | mksmith | 0 | 1 year 15 weeks ago |
| News Article | Recombinant Drugs and the Economics of Prefilled Syringes | mksmith | 0 | 1 year 15 weeks ago |
| News Article | Factors Enabling Targeted Drug Delivery Evolving | mksmith | 0 | 1 year 16 weeks ago |
| News Article | Pen Injectors Becoming Dominant Force in Many Therapeutic Sectors | mksmith | 0 | 1 year 16 weeks ago |
| News Article | Evolving Technology Creating Opportunities for Central Nervous System Therapeutics | mksmith | 0 | 1 year 16 weeks ago |
| News Article | Regional Factors Add Complexity to Autoimmune Disease Drug Development | mksmith | 0 | 1 year 17 weeks ago |
| News Article | Proteins & Peptides Driving Interest in Powder Drug Formulations | mksmith | 0 | 1 year 17 weeks ago |
| News Article | Proprietary Processes Take Center Stage in Therapeutic Vaccine Sector | mksmith | 0 | 1 year 18 weeks ago |
| News Article | In Spite of Setbacks, Therapeutic Cancer Vaccines Continue to Make Gains | mksmith | 0 | 1 year 19 weeks ago |
| News Article | Protein Therapeutics and the Marriage of Drugs and Devices | mksmith | 0 | 1 year 20 weeks ago |
| News Article | Business Issues Slowing Growth of Retractable Syringes | mksmith | 0 | 1 year 22 weeks ago |
| News Article | The Strategy and Business of Engineered Blood Substitutes | mksmith | 0 | 1 year 24 weeks ago |
| News Article | Needle-free Injection Continues to Search for Commercial Success | mksmith | 0 | 1 year 24 weeks ago |
| News Article | Advancing Nanoparticle Technology Creating Opportunities for Drug Developers | mksmith | 0 | 1 year 25 weeks ago |
| News Article | Advanced Wound Closure Techniques Replacing Sutures and Staples | mksmith | 0 | 1 year 28 weeks ago |
| News Article | Developers Finding Success of Injectable Drugs Dependent on Numerous Factors | mksmith | 0 | 1 year 28 weeks ago |
| News Article | Drugs Based on Immune Factors Set to Double in Value by 2011 | mksmith | 0 | 1 year 35 weeks ago |
| News Article | New Technologies, New Players Set to Challenge Asthma, COPD Therapeutic Sector | mksmith | 0 | 1 year 36 weeks ago |
| News Article | No Longer a Necessary Evil, New Drug Devices Exemplify Convenience | mksmith | 0 | 1 year 39 weeks ago |
|
